{
  "docId": "019dd923-5ca1-7489-b639-45501f4b359b",
  "docSlug": "158df8627a0b9aca",
  "documentTitle": "Opioid Conflicts Majority Staff Report",
  "authorId": "McKinsey",
  "authorName": "U.S. House Committee on Oversight and Reform",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "portrait",
  "aspectRatio": 0.773,
  "pageNumber": 15,
  "pageCount": 53,
  "prevPage": 14,
  "nextPage": 16,
  "slideType": "appendix_disclosure",
  "function": "summarize",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": "This page appears to be an excerpt from a formal report or investigative document, containing narrative text and extensive footnotes.",
  "elementsJson": [
    "paragraph",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5ca1-7489-b639-45501f4b359b/15",
  "deckHref": "/decks/019dd923-5ca1-7489-b639-45501f4b359b",
  "deckJsonHref": "/decks/019dd923-5ca1-7489-b639-45501f4b359b.json",
  "deckAnchorHref": "/decks/019dd923-5ca1-7489-b639-45501f4b359b#slide-15",
  "components": [
    {
      "bbox": {
        "h": 0.25,
        "w": 0.8,
        "x": 0.1,
        "y": 0.68
      },
      "kind": "disclaimer",
      "text": "55 MCK-HCOR-0086036; MCK-HCOR-0172253; MCK-HCOR-0155555, Pages 14-15; MCK-HCOR-0339527; MCK-HCOR-0172451; MCK-HCOR-0174776; MCK-HCOR-0172142. 56 MCK-HCOR-0174550 to MCK-HCOR-0174698 (McKinsey Purdue Engagement List)...",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c9b48ec8-0d79-44a0-969c-df4623dd2b8d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.8,
        "x": 0.1,
        "y": 0.26
      },
      "kind": "paragraph",
      "text": "Nora Gardner is among the most senior partners at McKinsey. She serves as the Managing Partner of McKinsey’s Washington D.C. office and, according to documents provided to the Committee, is a member of the firm’s Client Service Risk Committee.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0add9d4e-7f93-4000-b1f3-ec4dbb6ff558",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.8,
        "x": 0.1,
        "y": 0.46
      },
      "kind": "paragraph",
      "text": "Documents indicate that during this time, Ms. Gardner was also unofficially participating on Purdue matters. Ms. Gardner received invitations for 15 calls and meetings with Purdue between January 15, 2015, and April 1, 2015...",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0b5605fe-d799-49a6-89b3-62db82126fae",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.8,
        "x": 0.1,
        "y": 0.35
      },
      "kind": "paragraph",
      "text": "From January 2018 to March 2019, Ms. Gardner consulted on four projects at FDA, including on a project to modernize new drug programs. In January 2018, Ms. Gardner began a project at FDA to \"Design and implement the future state operating model...\"",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "323aa942-14a9-4442-ba45-c200bd9ffee1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.8,
        "x": 0.1,
        "y": 0.1
      },
      "kind": "paragraph",
      "text": "Ms. George first staffed a Purdue project in 2004 and appears to have intermittently assisted the manufacturer over the next 12 years. For instance, Ms. George appeared to brief Richard Sackler on foreign business opportunities in 2007...",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4fdd37ad-f86c-4b5f-b6be-372c735bcc23",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.8,
        "x": 0.1,
        "y": 0.6
      },
      "kind": "paragraph",
      "text": "The Committee has identified at least 16 additional consultants who worked for FDA and opioid manufacturers between 2008 and 2022. The Committee has outlined the contracts for 15 of these consultants falling below the full partner level...",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "95567458-e540-403a-914d-65757a0e37a7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.2,
        "x": 0.1,
        "y": 0.56
      },
      "kind": "title",
      "text": "Other Consultants",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "63490f72-039f-4f8e-b8e9-1fab52a4ffbe",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.2,
        "x": 0.1,
        "y": 0.22
      },
      "kind": "title",
      "text": "Nora Gardner",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ea13985a-f92c-46d2-a9b6-b8836a4b870e",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 28,
      "from": 6,
      "beatId": "ca9c3ab4-903c-4ff0-b53d-42335d2ce596",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Evidence & Proof",
      "beatSlug": "consultants-gambit-evidence-proof",
      "evidence": "The document presents extensive evidence of McKinsey's conflicts of interest, including consultant overlaps and contract details.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [
    {
      "to": 53,
      "from": 1,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "ee9686db-f8b5-4bc9-bf6e-2d29966ee033",
      "evidence": "The document implies the cost of inaction through its presentation of McKinsey's conflicts of interest and their potential impact on the opioid epidemic.",
      "position": 0,
      "objective": "What is the cost of inaction in addressing McKinsey's conflicts of interest?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}